proline has been researched along with Antibody Deficiency Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, M; Domínguez-Pinilla, N; Dorsey, MJ; Ho, V; Hubsch, A; Mabudian, M; Rishi, R; Rojavin, M; Soler-Palacín, P; Wong, D | 1 |
Mozes, E; Sela, M | 1 |
2 other study(ies) available for proline and Antibody Deficiency Syndrome
Article | Year |
---|---|
Clinical experience with an L-proline–stabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Europe; Female; Headache; Hospitalization; Humans; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Infant; Infections; Male; Middle Aged; Practice Patterns, Physicians'; Proline; Protein Stability; Retrospective Studies; United States; Young Adult | 2014 |
The role of the thymus in a genetically controlled defect of the immune response at the carrier level.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Antigens; Bone Marrow; Bone Marrow Cells; Carrier Proteins; Epitopes; Immunity, Maternally-Acquired; Immunization, Passive; Immunologic Deficiency Syndromes; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Peptides; Proline; Radiation Chimera; Rodent Diseases; T-Lymphocytes; Thymus Gland | 1974 |